Histological classification of ovarian cancer
- PMID: 12658347
- DOI: 10.1007/s007950300002
Histological classification of ovarian cancer
Abstract
The histology of ovarian tumors exhibits a wide variety of histological features. The histological classification of ovarian tumors by the World Health Organization (WHO) is based on histogenetic principles, and this classification categorizes ovarian tumors with regard to their derivation from coelomic surface epithelial cells, germ cells, and mesenchyme (the stroma and the sex cord). Epithelial ovarian tumors, which are the majority of malignant ovarian tumors, are further grouped into histological types as follows: serous, mucinous, endometrioid, clear cell, transitional cell tumors (Brenner tumors), carcinosarcoma, mixed epithelial tumor, undifferentiated carcinoma, and others. Clear cell and endometrioid carcinomas are highly associated with endometriosis. In stage distribution, serous carcinoma is found predominantly is stage III or IV. In contrast, clear cell and endometrioid carcinomas tend to remain confined to the ovary. Clear cell and endometrioid carcinomas may be unique histological types compared with serous carcinomas with respect to stage distribution and association with endometriosis.
Similar articles
-
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Pathology. 2011. PMID: 21716157 Review.
-
Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.Am J Surg Pathol. 2012 May;36(5):688-95. doi: 10.1097/PAS.0b013e31824b6eed. Am J Surg Pathol. 2012. PMID: 22498820
-
B7-H4 overexpression in ovarian tumors.Gynecol Oncol. 2006 Jan;100(1):44-52. doi: 10.1016/j.ygyno.2005.08.060. Epub 2005 Oct 26. Gynecol Oncol. 2006. PMID: 16256178
-
[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17631760 Chinese.
-
My approach to and thoughts on the typing of ovarian carcinomas.J Clin Pathol. 2008 Feb;61(2):152-63. doi: 10.1136/jcp.2007.049478. Epub 2007 Aug 17. J Clin Pathol. 2008. PMID: 17704261 Review.
Cited by
-
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis.Cancers (Basel). 2019 Oct 21;11(10):1608. doi: 10.3390/cancers11101608. Cancers (Basel). 2019. PMID: 31640297 Free PMC article. Review.
-
Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome.Cancer Manag Res. 2019 Jul 8;11:6275-6284. doi: 10.2147/CMAR.S206817. eCollection 2019. Cancer Manag Res. 2019. PMID: 31372034 Free PMC article.
-
Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1103-1108. doi: 10.31557/APJCP.2019.20.4.1103. Asian Pac J Cancer Prev. 2019. PMID: 31030480 Free PMC article.
-
Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development.PLoS One. 2013 Nov 1;8(11):e78417. doi: 10.1371/journal.pone.0078417. eCollection 2013. PLoS One. 2013. PMID: 24223801 Free PMC article.
-
Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer.Toxins (Basel). 2021 Jun 30;13(7):461. doi: 10.3390/toxins13070461. Toxins (Basel). 2021. PMID: 34209281 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical